JP Morgan Maintains Neutral on ArcBest, Raises Price Target to $117
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Brian Ossenbeck maintains ArcBest (NASDAQ:ARCB) with a Neutral and raises the price target from $85 to $117.
JP Morgan analyst Brian Ossenbeck maintains ArcBest (NASDAQ:ARCB) with a Neutral and raises the price target from $85 to $117.